GMP Grade Human Interleukin-2 (IL-2) from ACROBiosystems Inc.

The National Institutes of Health (NIH) intends to award a sole source contract to ACROBiosystems Inc. for the procurement of fifteen vials of CytoPak GMP Human IL-2 Protein. This protein is required for the Center for Cellular Engineering's approved manufacturing protocols, and substituting another manufacturer's product would require extensive process revalidation. The contract will support FDA-regulated cell and gene therapy manufacturing activities performed by the Center for Cellular Engineering. Key aspects of the job include: • Procurement of fifteen vials of CytoPak GMP Human IL-2 Protein • Support for FDA-regulated cell and gene therapy manufacturing activities • Requirement for validated products to ensure product safety, quality, and consistency • Potential for significant delays and increased costs if an alternate product is used